The impact of primary diseases is substantial, demanding groundbreaking therapeutic options. Cellular therapies represent a especially exciting avenue, offering the chance to regenerate damaged liver tissue and enhance clinical outcomes. Currently, research focuses on several methods, including the administration of mesenchymal cellular entities di